Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Editor's introduction: antipsychotic prescribing practices.

Susan M Essock1

  • 1Department of Psychiatry, Mount Sinai School of Medicine of New York University, NY 10029-6574, USA. susan.essock@mssm.edu

Schizophrenia Bulletin
|June 6, 2002
PubMed
Summary

This commentary reviews antipsychotic prescribing for schizophrenia, highlighting deviations from evidence-based practices. It identifies critical research gaps to improve clinical guidelines and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking Antipsychotic Comparisons: The Role of Prior Exposure and Tolerability.

The American journal of psychiatry·2026
Same author

Detection of Diabetes and Hypertension Comorbidities Among Adult Psychiatric Inpatients.

The Journal of nervous and mental disease·2025
Same author

Was the COVID-19 Pandemic Decline in Psychiatric Beds Unusually Steep?

JAMA network open·2025
Same author

Community, Hospital, and Patient Factors Contributing to Ethnoracial Disparities in Follow-Up After Psychiatric Hospitalization.

Psychiatric services (Washington, D.C.)·2023
Same author

Patient-, Hospital-, and System-Level Factors Associated With 30-Day Readmission After a Psychiatric Hospitalization.

The Journal of nervous and mental disease·2022
Same author

Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations.

AIDS (London, England)·2022

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Pharmacy
  • Evidence-Based Medicine

Background:

  • Antipsychotic prescribing for schizophrenia often deviates from evidence-based guidelines.
  • Translating research findings into clinical practice remains a significant challenge.
  • Existing practice patterns raise important questions not yet addressed by research.

Purpose of the Study:

  • To introduce a collection of articles examining antipsychotic prescribing for schizophrenia.
  • To identify discrepancies between current practices and evidence-based recommendations.
  • To highlight research gaps and inform future research agendas.

Main Methods:

  • Review of antipsychotic prescribing practices in schizophrenia.
  • Analysis of adherence to evidence-based guidelines.

Related Experiment Videos

  • Identification of variations and knowledge gaps.

    • Main Results:

    • Significant variations exist between prescribed antipsychotic practices and evidence-based recommendations.
    • Clinically important research findings are not consistently implemented in practice.
    • Routine clinical practice generates questions that require further research.

    Conclusions:

    • Delineating evidence-based practices is essential for guidelines and performance monitoring.
    • Identifying practice-knowledge gaps is crucial for developing a targeted research agenda.
    • Bridging the gap between research and practice is vital for optimizing schizophrenia treatment.